2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a
Chemical compound
From Wikipedia, the free encyclopedia
2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH) is a photosensitiser chemical that is used in photodynamic therapy.[1]
| Names | |
|---|---|
| Other names
Photochlor | |
| Identifiers | |
3D model (JSmol) |
|
| Abbreviations | HPPH |
| ChemSpider | |
PubChem CID |
|
| UNII | |
| |
| |
| Properties | |
| C39H48N4O4 | |
| Molar mass | 636.837 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
It is being developed under the brand name Photochlor.
Clinical trials
A phase I/II clinical trial started in 1997 for esophageal cancer.[2]
A phase II trial for non-small cell lung cancer is due to run from 2007 to 2011.[3]
